Tag: Evaluation

CONSULTANCY

REACH requires strategic thinking to get your company ready to pass the various phases of the legislation. ReachCentrum offers REACH expert consultancy to support REACH implementation within companies and other stakeholder groups, in order to help you adopt the most effective strategy.
ReachCentrum has gained a highly respected reputation in delivering consultancy on chemicals regulation. Our focus is on providing practical advice and guidance for those companies needing to fulfil their REACH obligations, whilst fully respecting your business strategy.

ReachCentrum‘s approach is to listen to and carefully analyse each customers’ needs, and then to find the best solution adapted to their requirements and fine tune the support needed throughout the registration, evaluation and authorisation phases of REACH.

Our service covers:

  • Strategic help for your REACH business management
  • Cost effective approach towards the REACH phases

Read more

Do you want to know more about the REACH priorities after the second registration deadline?

At the conference, organised by IBC Legal and Tax Conferences, high level speakers from industry and authorities will tackle several REACH topics such as REACH after the Commission review 2012,  preparation for inspections, REACH evalution, authorisation in the supply chain and much more.
ReachCentrum, with its training manager Vincenzo Girardi will address on 26 June the REACH priorities after the second registration deadline, including:

  • REACH audit - what are we doing within the company to be compliant with REACH SIEF activities?
  • Envisaging the eventual post registration activities of a SIEF - testing proposals are approved
  • Cost sharing re-evaluated eSDS - the production and distribution of extended safety data sheets adapted to the needs of customers
  • How do I achieve this dossier evaluation? Reviewing the quality of the actual dossier submitted to ECHA before ECHA uses it for substance evaluation
  • How to cope with inspections on site REACH?
  • The ‘A’ in REACH - what happens if authorisation becomes reality?
  • REACH knowledge drain - who needs to know what about REACH within the company and how to avoid losing knowledge when people leave

Further information is available at conference website

ECHA's Evaluation Progress Report 2012 published

The aim of such reports is to describe the progress made in evaluating registration dossiers in substance evaluation, advises on the most frequent observations and shortcomings encountered during the processes of dossier evaluation and makes recommendations to improve the quality of future registrations.

The 2012 Report shows that the registrations dossiers still raise quality issues and as consequence affect their compliance with REACH.

Hence, the most common shortcomings found by ECHA in the registrations dossiers triggered the following five topics:

  • Identifying your substance.
  • Identifying the test material.
  • Making full use of all relevant information.
  • Providing clear use and exposure information.
  • Making use of ECHA support.


to be  the ones on which the Report gives specific recommendations.

It is important to note also  that the Report “does not cover assessment of the quality of dossiers for intermediates that were the subject of a large-scale screening action in the past year. Registrants that prepare such dossiers for the next registration deadline are urged to also take note of the news alerts and web pages covering this action.”

The ECHA press release is available here.

EVALUATION SUPPORT

Your registration is filed and you have received your registration number - you have successfully registered. However, REACH is not over yet - your dossier may be evaluated by ECHA.

Once a dossier is submitted under the registration process, it might be subject to Evaluation under REACH.
Under dossier Evaluation, European Chemicals Agency (ECHA) will evaluate all testing proposals. Of all dossiers per tonnage band 5% will undergo a compliance check by ECHA.
For substance Evaluation the Member States check if a substance can constitute a risk to human health or to the environment.

Do you have a procedure in place for this? When do you need to inform or consult the SIEF?

There are two types of evaluation: dossier evaluation and substance evaluation.

Dossier evaluation
The joint submission dossier is evaluated on its content. This can be related to the testing proposals which are all checked to ensure that tests are justified and adequate to avoid unnecessary animal testing and costs. Further to this, 5% of all dossiers in a tonnage band will undergo evaluation in form of a compliance check to ensure their compliance with registration requirements. Priority is given here to dossiers with certain characteristics, e.g. dossiers submitted separately, or using a read across approach. 

Substance evaluation
The submitted dossier is checked to ascertain whether the use of the substance constitutes a risk to human health or the environment.

Read more